Both in Lab Analytical Instruments
Seer vs Harvard Bioscience
Over the past year SEER returned −23.8% and HBIO returned +49.8%; their daily moves had a correlation of 0.01.
SEER −23.8% HBIO +49.8%Growth of $1, one year, split-adjusted
| Metric | SEER | HBIO |
|---|---|---|
| Price | $1.73 | $8.60 |
| Market cap | $95.8M | $39.1M |
| Today | +2.98% | −3.37% |
| 1 month | −23.1% | +3.1% |
| 6 months | −11.3% | +34.4% |
| Year to date | −5.5% | +28.6% |
| 1 year | −22.4% | +36.5% |
| Revenue growth (YoY) | −23.4% | +11.1% |
| Gross margin | 48.5% | 55.6% |
| Net margin | −544.8% | −12.8% |
| P/E (TTM) | — | — |
| Price / sales | 6.7× | 0.4× |
| Net cash | $152.9M | -$30.2M |
| Dividend yield | — | — |
| Volatility (60d) | 44.8% | 36.4% |
| Short % of float | 0.3% | 1.5% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).